• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data on how long-term exposure may affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication must consider the benefits of taking it against the possible risks for the fetus. Physicians don't have the data needed to give clear guidelines however they can provide information about risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure correct case classification and to limit the possibility of bias.

The study conducted by the researchers was not without its limitations. In particular, they were not able to differentiate the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medications or confounded by co-morbidities. Additionally the study did not examine long-term offspring outcomes.

The study did show that infants whose mothers took ADHD medications during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies could be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman’s disorder. Doctors should discuss with their patients about this issue and as much as possible, assist them develop coping strategies that may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors must weigh their own knowledge and experience, as well as the experiences of other doctors, and the research that has been conducted on the subject.

The issue of potential risks to infants is extremely difficult. Many studies on this subject are based on observations rather than controlled research and their findings are often contradictory. In addition, most studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies have a neutral or slightly negative effect. In each case, a careful evaluation of the risks and benefits is required.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for those suffering from the disorder. A loss of medication may affect the ability to safely drive and complete work-related tasks, which are essential aspects of normal life for those with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy, educate their family members, colleagues, and their friends about the condition, its impact on daily functioning and the benefits of continuing the current treatment regimen. It can also help a woman feel supported in her decision. It is important to note that certain medications can pass through the placenta, so if the patient decides to discontinue her adhd medication titration medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the medications could have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Using two massive data sets researchers were able to look at more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The authors of the study found no connection between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The findings are in line with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior Adhd medication titration to the time of pregnancy. This risk increased during the latter part cost of adhd medication uk pregnancy when many women began to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth and also have an insufficient Apgar after birth and had a baby that required help breathing after birth. However the researchers of the study were unable to eliminate bias due to selection by limiting the study to women who didn't have other medical issues that could have contributed to these findings.

The researchers hope that their research will help inform the clinical decisions of doctors who treat pregnant women. The researchers advise that, while discussing benefits and risks are important, the choice about whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors caution that, even though stopping the medication is a possibility to think about, it isn't advised because of the high incidence of depression and mental health issues in women who are expecting or have recently given birth. Further, the research suggests that women who decide to stop taking their medications are more likely to have difficulties getting used to life without them after the birth of their baby.

Nursing

The responsibilities of a new mother can be overwhelming. Women with strongest adhd medication for adults may face a lot of challenges when they have to manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. However, the amount of exposure to medications by the infant can differ based on dosage, frequency it is administered and the time of day it is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or breast milk. The impact on the health of a newborn isn't completely known.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication with the potential risks to the foetus. In the meantime, until more information is available, GPs can a doctor prescribe adhd medication ask pregnant patients whether they have any history of ADHD or if they intend to take medication during the perinatal phase.

A increasing number of studies have proven that most women can safely continue their ADHD medication during pregnancy and breastfeeding. In the end, more and more patients opt to do this and in consultation with their doctor they have discovered that the benefits of maintaining their current medication far outweigh any potential risks.

Women who suffer from adhd medication not working who are planning to nurse should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from managing adhd without medication adults recognize the signs and the underlying disorder. They should also be educated about treatment options and build coping mechanisms. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatrists. Pregnancy counselling should include discussion of a management plan for both mother and child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.